73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct
Enhanced recovery program shown to successfully reduce opioid use after pancreatic cancer surgery

Enhanced recovery program shown to successfully reduce opioid use after pancreatic cancer surgery

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainBy improving hospital care pathways, researchers from The University of Texas MD Anderson Cancer Center succes

Enhanced recovery program shown to successfully reduce opioid use after pancreatic cancer surgery

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainBy improving hospital care pathways, researchers from The University of Texas MD Anderson Cancer Center succes
Study pinpoints origin of pediatric brain tumor type and shows it may be preventable

Study pinpoints origin of pediatric brain tumor type and shows it may be preventable

by The Hospital for Sick ChildrenCredit: Unsplash/CC0 Public DomainAn aggressive type of pediatric brain tumor, medulloblastoma, exists in a pre-malignant form at birth after initially developing duri

Study pinpoints origin of pediatric brain tumor type and shows it may be preventable

by The Hospital for Sick ChildrenCredit: Unsplash/CC0 Public DomainAn aggressive type of pediatric brain tumor, medulloblastoma, exists in a pre-malignant form at birth after initially developing duri
Patients treated outside NCI centers less likely to receive high-cost lung cancer drugs

Patients treated outside NCI centers less likely to receive high-cost lung cancer drugs

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center Deputy Director and Associate Dean for Research at the Colorado School of Public Health. Credit: University of Colorado Cancer Ce

Patients treated outside NCI centers less likely to receive high-cost lung cancer drugs

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center Deputy Director and Associate Dean for Research at the Colorado School of Public Health. Credit: University of Colorado Cancer Ce
Natural mechanism causes 50-fold increase in T-cell activation sensitivity

Natural mechanism causes 50-fold increase in T-cell activation sensitivity

byLatrobe UniversityThymic cortical T cell deletion induced by a CDR3 cysteine. TCR-retrogenic mice expressing the 6218 or 6218αC TCR were made as described in Fig.1, except that all recip

Natural mechanism causes 50-fold increase in T-cell activation sensitivity

byLatrobe UniversityThymic cortical T cell deletion induced by a CDR3 cysteine. TCR-retrogenic mice expressing the 6218 or 6218αC TCR were made as described in Fig.1, except that all recip
Novel classification can lead to new ways to diagnose and treat cancer

Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0

Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0
New calculation tool identifies a group of cancer patients with favorable prognosis

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo
Learning the language of cells to beat cancer

Learning the language of cells to beat cancer

byThe Mount Sinai HospitalIdealized workflow utilizing multiomic tissue profiling for achieving personalized medicine. Workflow includes integration of scRNA-seq and ST along with other tissue p

Learning the language of cells to beat cancer

byThe Mount Sinai HospitalIdealized workflow utilizing multiomic tissue profiling for achieving personalized medicine. Workflow includes integration of scRNA-seq and ST along with other tissue p
Private and secure generative AI tool supports operations and research in a cancer center

Private and secure generative AI tool supports operations and research in a cancer center

byDana-Farber Cancer InstituteCredit: CC0 Public DomainDana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or ho

Private and secure generative AI tool supports operations and research in a cancer center

byDana-Farber Cancer InstituteCredit: CC0 Public DomainDana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or ho
Potential new series of drugs targeting cancer-driving protein BCL6

Potential new series of drugs targeting cancer-driving protein BCL6

byInstitute of Cancer ResearchThe BCL6 BTB domain dimer (in grey/green) and compound hits in pink, superimposed on each other in the main compound binding site. Credit: Dr Rob van Montfort lab /

Potential new series of drugs targeting cancer-driving protein BCL6

byInstitute of Cancer ResearchThe BCL6 BTB domain dimer (in grey/green) and compound hits in pink, superimposed on each other in the main compound binding site. Credit: Dr Rob van Montfort lab /
Thousands of cervical screening samples are waiting to be tested, says report

Thousands of cervical screening samples are waiting to be tested, says report

by Cancer Research UKCredit: CC0 Public DomainMore than 150,000 cervical screening samples were waiting to be tested by NHS laboratories across England last year, according to a report.A study fr

Thousands of cervical screening samples are waiting to be tested, says report

by Cancer Research UKCredit: CC0 Public DomainMore than 150,000 cervical screening samples were waiting to be tested by NHS laboratories across England last year, according to a report.A study fr
Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur